Literature DB >> 29556694

Comments on treatment of the aneurysmal bone cyst by percutaneous intracystic sclerotherapy using ethanol ninety five percent in children.

Dan Ionuţ Cosma1, Andrei Corbu2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29556694     DOI： 10.1007/s00264-018-3894-y

Source DB:  PubMed          Journal:  Int Orthop        ISSN： 0341-2695            Impact factor:   3.075


× No keyword cloud information.
  6 in total

1.  Recurrence of aneurysmal bone cysts in young children: a multicentre study.

Authors:  Jérôme Cottalorda; Rémi Kohler; Franck Chotel; Jérôme Sales de Gauzy; Gérard Lefort; Djamel Louahem; Sophie Bourelle; Alain Diméglio
Journal:  J Pediatr Orthop B       Date:  2005-05       Impact factor: 1.041

2.  Treatment of the aneurysmal bone cyst by percutaneous intracystic sclerotherapy using ethanol ninety five percent in children.

Authors:  Alexandru Ulici; Daniel-Catalin Florea; Madalina Carp; Alin Ladaru; Iulia Tevanov
Journal:  Int Orthop       Date:  2018-02-28       Impact factor: 3.075

3.  Denosumab treatment in aneurysmal bone cyst: Evaluation of nine cases.

Authors:  Nilgun Kurucu; Canan Akyuz; Fatma Bilge Ergen; Bilgehan Yalcin; Kemal Kosemehmetoglu; Mehmet Ayvaz; Ali Varan; Burca Aydin; Tezer Kutluk
Journal:  Pediatr Blood Cancer       Date:  2017-12-29       Impact factor: 3.167

4.  Percutaneous Doxycycline Treatment of Juxtaphyseal Aneurysmal Bone Cysts.

Authors:  William E Shiels; Allan C Beebe; Joel L Mayerson
Journal:  J Pediatr Orthop       Date:  2016-03       Impact factor: 2.324

5.  Percutaneous doxycycline treatment of aneurysmal bone cysts with low recurrence rate: a preliminary report.

Authors:  William E Shiels; Joel L Mayerson
Journal:  Clin Orthop Relat Res       Date:  2013-05-14       Impact factor: 4.176

6.  Sclerotherapy using Surgiflo and alcohol: a new alternative for the treatment of aneurysmal bone cysts.

Authors:  I Ghanem; N Nicolas; M Rizkallah; S Slaba
Journal:  J Child Orthop       Date:  2017-12-01       Impact factor: 1.548
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.